O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis
出版年份 2021 全文链接
标题
O-GlcNAcylation ameliorates the pathological manifestations of Alzheimer’s disease by inhibiting necroptosis
作者
关键词
-
出版物
Science Advances
Volume 7, Issue 3, Pages eabd3207
出版商
American Association for the Advancement of Science (AAAS)
发表日期
2021-01-14
DOI
10.1126/sciadv.abd3207
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- O-GlcNAcylation as a Therapeutic Target for Alzheimer’s Disease
- (2020) Jinsu Park et al. NEUROMOLECULAR MEDICINE
- Neuronal Aquaporin 1 Inhibits Amyloidogenesis by Suppressing the Interaction Between Beta-Secretase and Amyloid Precursor Protein
- (2020) Jinsu Park et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Sodium rutin ameliorates Alzheimer’s disease–like pathology by enhancing microglial amyloid-β clearance
- (2019) Rui-Yuan Pan et al. Science Advances
- O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3
- (2019) Xinghui Li et al. IMMUNITY
- Preventive approach for overcoming dementia
- (2019) HeeYang Lee et al. ARCHIVES OF PHARMACAL RESEARCH
- NRF2/ARE pathway negatively regulates BACE1 expression and ameliorates cognitive deficits in mouse Alzheimer’s models
- (2019) Gahee Bahn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteomic identification of altered protein O-GlcNAcylation in a triple transgenic mouse model of Alzheimer's disease
- (2018) Antonella Tramutola et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Interleukin 4 modulates microglia homeostasis and attenuates the early slowly progressive phase of amyotrophic lateral sclerosis
- (2018) Chiara Rossi et al. Cell Death & Disease
- Pharmacological Inhibition of Necroptosis Protects from Dopaminergic Neuronal Cell Death in Parkinson’s Disease Models
- (2018) Angelo Iannielli et al. Cell Reports
- Microglial signatures and their role in health and disease
- (2018) Oleg Butovsky et al. NATURE REVIEWS NEUROSCIENCE
- Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies
- (2018) Tiffany S. Pinho et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
- (2018) Junying Yuan et al. NATURE REVIEWS NEUROSCIENCE
- SustainedO-GlcNAcylation reprograms mitochondrial function to regulate energy metabolism
- (2017) Ee Phie Tan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model
- (2017) Seung Hyun Baek et al. JOURNAL OF NEUROSCIENCE
- Dementia prevention, intervention, and care
- (2017) Gill Livingston et al. LANCET
- Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
- (2017) Nicholas B. Hastings et al. Molecular Neurodegeneration
- Necroptosis activation in Alzheimer's disease
- (2017) Antonella Caccamo et al. NATURE NEUROSCIENCE
- A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
- (2017) Jun Wang et al. Nature Reviews Neurology
- RIPK1 promotes inflammation and β-amyloid accumulation in Alzheimer’s disease
- (2017) David C. Rubinsztein PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PHARMACOKINETICS AND PHARMACODYNAMICS TO SUPPORT CLINICAL STUDIES OF MK-8719: AN O-GLCNACASE INHIBITOR FOR PROGRESSIVE SUPRANUCLEAR PALSY
- (2016) Punam Sandhu et al. Alzheimers & Dementia
- Aβ-affected pathogenic induction of S-nitrosylation of OGT and identification of Cys-NO linkage triplet
- (2016) In-Hyun Ryu et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP/PS1 mice
- (2016) Seung‐Hoon Yang et al. EMBO Molecular Medicine
- Thiamet G mediates neuroprotection in experimental stroke by modulating microglia/macrophage polarization and inhibiting NF-κB p65 signaling
- (2016) Yating He et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Loss ofO-GlcNAc glycosylation in forebrain excitatory neurons induces neurodegeneration
- (2016) Andrew C. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
- (2016) Yasushi Ito et al. SCIENCE
- Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
- (2016) Hye Yun Kim et al. Jove-Journal of Visualized Experiments
- Pin1 promotes neuronal death in stroke by stabilizing Notch intracellular domain
- (2015) Sang-Ha Baik et al. ANNALS OF NEUROLOGY
- Mitochondrial ATP synthase activity is impaired by suppressedO-GlcNAcylation in Alzheimer's disease
- (2015) Moon-Yong Cha et al. HUMAN MOLECULAR GENETICS
- Conditional Knock-out Reveals a Requirement forO-LinkedN-Acetylglucosaminase (O-GlcNAcase) in Metabolic Homeostasis
- (2015) Chithra Keembiyehetty et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of Necroptosis in Multiple Sclerosis
- (2015) Dimitry Ofengeim et al. Cell Reports
- Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain
- (2014) Sarah Förster et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
- (2014) Scott A Yuzwa et al. Molecular Neurodegeneration
- O-GlcNAcase is essential for embryonic development and maintenance of genomic stability
- (2012) Yong Ryoul Yang et al. AGING CELL
- Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer’s disease
- (2012) A-Ryeong Gwon et al. AGING CELL
- The RIP1/RIP3 Necrosome Forms a Functional Amyloid Signaling Complex Required for Programmed Necrosis
- (2012) Jixi Li et al. CELL
- Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation
- (2012) Scott A Yuzwa et al. Nature Chemical Biology
- O-linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment
- (2012) Chaeyoung Kim et al. NEUROBIOLOGY OF AGING
- Intracerebral microinjection of interleukin-4/interleukin-13 reduces β-amyloid accumulation in the ipsilateral side and improves cognitive deficits in young amyloid precursor protein 23 mice
- (2012) K. Kawahara et al. NEUROSCIENCE
- O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP)
- (2010) Kristin T. Jacobsen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elevation of Global O-GlcNAc in Rodents Using a Selective O-GlcNAcase Inhibitor Does Not Cause Insulin Resistance or Perturb Glucohomeostasis
- (2010) Matthew S. Macauley et al. CHEMISTRY & BIOLOGY
- A Modified Coupled Enzyme Method for O-linked GlcNAc Transferase Activity Assay
- (2009) Lianwen Zhang et al. BIOLOGICAL PROCEDURES ONLINE
- Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease
- (2009) F. Liu et al. BRAIN
- Necroptosis: A Specialized Pathway of Programmed Necrosis
- (2008) Lorenzo Galluzzi et al. CELL
- Inflammatory Response in the Hippocampus of PS1M146L/APP751SL Mouse Model of Alzheimer's Disease: Age-Dependent Switch in the Microglial Phenotype from Alternative to Classic
- (2008) S. Jimenez et al. JOURNAL OF NEUROSCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started